Prothena reported 139.17M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 131.61M 16.39M
Adamas Pharmaceuticals ADMS:US 25.9M 3.92M
Akebia Therapeutics AKBA:US $ 48.76M 4.16M
Alexion Pharmaceuticals ALXN:US $ 1636.5M 44.7M
ALKERMES ALKS:US $ 294.14M 9.58M
Alnylam Pharmaceuticals ALNY:US $ 187.63M 32.92M
Amgen AMGN:US $ 6706M 180M
Biogen BIIB:US $ 2778.9M 3.9M
Biomarin Pharmaceutical BMRN:US $ 408.74M 92.95M
Bluebird Bio BLUE:US $ 22.68M 15.2M
Exelixis EXEL:US $ 328.42M 56.75M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Intercept Pharmaceuticals ICPT:US $ 92.83M 3.75M
Intra Cellular Therapies ITCI:US $ 22.21M 2.16M
IONIS PHARMACEUT IONS:US $ 133M 7.25M
Macrogenics MGNX:US $ 15.66M 15.1M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Neurocrine Biosciences NBIX:US $ 296M 7.1M
Prothena PRTA:US 139.17M 79.1M
Regeneron Pharmaceuticals REGN:US $ 3452.8M 1685.7M
Seattle Genetics SGEN:US $ 424.06M 35.58M
Ultragenyx Pharmaceutical RARE:US $ 81.65M 5.33M
Vertex Pharmaceuticals VRTX:US $ 1984.16M 190.79M
Xoma XOMA:US $ 940K 39K
YTE INCY:US $ 812.99M 107.28M